Elderly Follicular Lymphoma Patients

$Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies: 3-Year Follow-up from a Pivotal Phase II Study$

9:31

Mosunetuzumab Monotherapy Continues to Demonstrate Durabl…

10 个月之前

onclive.com

3:27

Subcutaneous Mosunetuzumab in Follicular Lymphoma

7 个月之前

onclive.com

0:15

Follicular Lymphoma Facts

已浏览 483 次11 个月之前

FacebookAbbVie

Dr Shouse on the Importance of NGS Testing in Follicular Lympho…

2 个月之前

onclive.com

Dr Nowakowski on Unmet Needs to be Addressed in R/R Follicular Ly…

1 个月前

onclive.com

$Dr Dahiya on the FDA Approval of Liso-Cel for Relapsed/Refractory Follicular Lymphoma$

Dr Dahiya on the FDA Approval of Liso-Cel for Relapsed/Refractory …

5 个月之前

onclive.com

Dr Andorsky on Real-World Treatment Patterns With BTK Inhi…

11 个月之前

onclive.com

Dr Murthy on the Use of CAR T-Cell Therapy in Elderly or Frail Patient…

2023年10月30日

onclive.com

1:00

Robert Jenkins has been... - Dana-Farber Cancer Institute

已浏览 291 次3 个月之前

FacebookDana-Farber Cancer Institute

Long-Term Data With Copanlisib in Follicular Lymphoma

2018年1月26日

onclive.com

1:17

Dr Leslie on the Clinical Benefit of Axi-Cel in Elderly Patients With R/…

10 个月之前

onclive.com

New study shows immunotherapy increases survival in Hodgkin lym…

3 周前

13wham.com

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With …

9 个月之前

onclive.com

Dr Mehta on Risks of CAR T-cell Therapy in Heavily Pretreated Ly…

1 个月前

onclive.com